I am a
Home I AM A Search Login

Papers of the Week


Front Med (Lausanne)


Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie’s Disease: An Evidence-Based Analysis.


Cao D, Li J, Lu Y, Huang Y, Chen B, Chen Z, Shen Y, Liu L, Wei Q
Front Med (Lausanne). 2022; 9:780956.
PMID: 35252236.


Peyronie's disease (PD) is a chronic wound healing disorder, mainly involving tunica albuginea. Collagenase Clostridium Histolyticum (CCH) has shown its effectiveness in treating PD, but its efficacy and safety remain controversial, which propelled us to conduct the first evidence-based research on this topic.